3 Rheumatoid Arthritis Clinical Trials in Murrieta, CA (2026)

Q: How do I join a clinical trial in Murrieta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Murrieta research site will contact you.

Recruiting Rheumatoid Arthritis Studies in Murrieta

NCT05488340Recruiting

A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)

This is a Phase 2 superiority study of LBP-EC01, a recombinant bacteriophage cocktail, with an initial open-label 3-arm pharmacokinetic (PK) lead-in portion of 30 patients to evaluate the optimal dosi...

Murrieta, CAPHASE2318 participantsLocus Biosciences

View Study Details

NCT05641688Recruiting

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Al...

Murrieta, CAPHASE3200 participantsLife Molecular Imaging Ltd

View Study Details

NCT06029972Recruiting

Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis

The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will comp...

Murrieta, CAPHASE2176 participantsGilead Sciences

View Study Details

About Rheumatoid Arthritis Clinical Trials in Murrieta

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 3 rheumatoid arthritis clinical trials recruiting participants in Murrieta, CA. These studies are seeking a combined 694 participants. Research is being sponsored by Locus Biosciences, Life Molecular Imaging Ltd, Gilead Sciences. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Murrieta — FAQ

Are there rheumatoid arthritis clinical trials in Murrieta?

Yes, there are 3 rheumatoid arthritis clinical trials currently recruiting in Murrieta, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Murrieta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Murrieta research site will contact you about next steps.

Are clinical trials in Murrieta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Murrieta studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 3 active trials in Murrieta are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated July 22, 2026 from ClinicalTrials.gov